SynteractHCR Adds Another Three Senior Executives To Management Team With Both U.S. and International Clinical Trials Operations Experience

Their newest senior executives include: Heather Davis, executive director of U.S. Project Management; Zia Haque, executive director, Clinical Data Management, and John Whitaker, Ph.D. as executive director, Biostatistics. All will report to Marlo M. Vasquez, vice president, U.S. Operations at SynteractHCR.

ReForm Biologics Appoints John M. Sorvillo, Ph.D., as Chief Executive Officer

April 19, 2017 ReForm Biologics, a pharmaceutical technology company that develops proprietary excipients to improve biologic formulations, announced today that the Company’s Board of Directors has appointed John M. Sorvillo, Ph.D., as Chief Executive Officer. Reform Biologics notes John...

Toshiba Medical Names Dan Skyba Director of Ultrasound Business Unit

Dan Skyba will be responsible for developing and implementing tactical marketing programs that build on growth and profitability for the business unit.

Surmodics Appoints Lisa Wipperman Heine to Its Board of Directors: Effective April 12, 2017

April 17, 2017 Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced the addition of Lisa Wipperman Heine to the Company’s Board of Directors, effective on...

resTORbio Appoints Joan Mannick, M.D., as Chief Medical Officer: Will Lead Resarch and Development Activities

In this role, Joan Mannick, MD will lead research and development activities for resTORbio.

Robert DeRyke Named President and CEO of Terumo Cardiovascular Group: Effective April 1, 2017

April 7, 2017 Robert DeRyke has been appointed President and CEO of Terumo Cardiovascular (CV) Group effective April 1, 2017, following the retirement of long-time President and CEO Mark Sutter. In this position, Robert DeRyke will lead Terumo's global...

Acelity New President Named: Andrew Eckert

April 5, 2017 Acelity L.P. Inc., announced that it has named R. Andrew Eckert as President and Chief Executive Officer. Andrew Eckert succeeds Joseph Woody, who is leaving Acelity following the successful divestiture of the company’s LifeCell division...

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.